Acute Blood Pressure Targets in Ischemic Stroke, ICH, and SAH

Few bedside questions are asked more often during a stroke code than “what is the blood pressure target?” The honest answer is that the target is a moving number set by the diagnosis, the time course, and whether reperfusion has been attempted. The same systolic pressure of 180 mm Hg is dangerous before thrombolysis, expected and tolerated in an untreated ischemic stroke, and frankly too high in a freshly secured subarachnoid hemorrhage. This page collects the numbers most stroke teams actually use, anchors them to the trials behind them, and flags the places where guidelines and institutions diverge. It is for clinician education only and is not a substitute for your own institutional protocol or individualized bedside judgment.

Ischemic stroke around thrombolysis

Before giving alteplase (tPA) or tenecteplase (TNK), blood pressure must be below 185/110 mm Hg, and it must stay there. This is the threshold above which the bleeding risk of lysis is considered unacceptable, and it is a hard gate — if you cannot get under it safely with a titratable agent, the patient is not a lytic candidate at that moment.

Once the lytic is running, the target tightens to below 180/105 mm Hg for the first 24 hours. The rationale is the same: a reperfused or partially lysed vessel bed is vulnerable to hemorrhagic transformation, and the post-lysis window is where symptomatic intracranial hemorrhage clusters. Check pressures frequently per protocol and treat promptly when they drift up.

Ischemic stroke not reperfused: permissive hypertension

If the patient is not getting a lytic and not going for thrombectomy, the operating principle is permissive hypertension. The elevated pressure is often supporting perfusion of threatened penumbra, and reflexively normalizing it can extend the infarct. The widely used threshold is to treat only if blood pressure exceeds 220/120 mm Hg, or earlier if there is a competing indication — active end-organ involvement such as acute coronary syndrome, aortic dissection, hypertensive encephalopathy, acute heart failure, or pre-eclampsia. When you do treat in this setting, aim for a modest reduction (on the order of 15 percent in the first day) rather than normalization.

After successful thrombectomy

Once a large-vessel occlusion has been opened with successful reperfusion (TICI 2b–3), the brain that was ischemic is now reperfused and at risk for hemorrhage, so most institutions target something tighter than the untreated-stroke ceiling — commonly in the range of roughly below 140/90 to below 160/90 mm Hg. The exact number varies by center and by how complete reperfusion was, which is precisely why no universal target exists.

The critical caveat is that tighter is not better. ENCHANTED2/MT randomized patients with successful endovascular reperfusion to an intensive systolic target below 120 mm Hg versus a less intensive target of 140–180 mm Hg, and the intensive arm did worse — the trial was stopped early for worse functional recovery and more early neurological deterioration with aggressive lowering.⁴ BP-TARGET, comparing an intensive systolic target of 100–129 mm Hg against 130–185 mm Hg after thrombectomy, found no reduction in intraparenchymal hemorrhage from the tighter target.³ The practical takeaway: avoid both extremes — control clearly elevated pressure, but do not drive it down aggressively after a successful recanalization.

Acute intracerebral hemorrhage

In spontaneous ICH presenting with elevated systolic pressure, the conventional move is to lower systolic toward approximately 140 mm Hg. INTERACT2 randomized patients to an intensive systolic target below 140 mm Hg versus guideline-recommended below 180 mm Hg; the primary outcome of death or major disability was not significantly reduced, though an ordinal analysis of the modified Rankin distribution favored intensive lowering.¹ ATACH-2 then tested a more aggressive systolic target of 110–139 mm Hg against 140–179 mm Hg using intravenous nicardipine and found no benefit in death or disability, along with more renal adverse events in the intensive arm.²

Read together, these trials support lowering toward roughly 140 mm Hg as reasonable and safe, while cautioning against pushing much lower in pursuit of marginal gains. Smooth, sustained control matters more than hitting a precise number — large swings and overshoot are what tend to cause trouble. Always follow your institution’s ICH protocol, which may specify a target range and an upper limit.

Aneurysmal subarachnoid hemorrhage and choosing agents

In aneurysmal SAH before the aneurysm is secured, the priority is to limit rebleeding while preserving cerebral perfusion. A commonly used target is to keep systolic below 160 mm Hg until the aneurysm is clipped or coiled; after securing, targets are generally liberalized and management shifts toward maintaining perfusion and managing delayed cerebral ischemia. Confirm the specific number with your neurosurgical and neurocritical-care colleagues, as practice varies.

For agents, reach for short-acting, titratable intravenous drugs:

• IV nicardipine or clevidipine for a smooth, controllable infusion — the workhorses for sustained titration in all of these settings.
• IV labetalol for bolus dosing when you need a quick step down (mind bradycardia and bronchospasm contraindications).
• Avoid sodium nitroprusside in acute brain injury — it can raise intracranial pressure, cause cerebral vasodilation and steal, and carries cyanide-toxicity risk on prolonged infusion.